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Abstract
Interaction measured on the additive scale has been argued to be better correlated with biologic
interaction than when measured on the multiplicative scale. Measures of interaction on the additive
scale have been developed using risk ratios. However, in studies that use odds ratios as the sole
measure of effect, the calculation of these measures of additive interaction is usually performed by
directly substituting odds ratios for risk ratios. Yet assessing additive interaction based on replacing
risk ratios by odds ratios in formulas that were derived using the former may be erroneous. In this
paper, we evaluate the extent to which three measures of additive interaction – the interaction
contrast ratio (ICR), the attributable proportion due to interaction (AP), and the synergy index (S),
estimated using odds ratios versus using risk ratios differ as the incidence of the outcome of
interest increases in the source population and/or as the magnitude of interaction increases. Our
analysis shows that the difference between the two depends on the measure of interaction used,
the type of interaction present, and the baseline incidence of the outcome. Substituting odds ratios
for risk ratios, when calculating measures of additive interaction, may result in misleading
conclusions. Of the three measures, AP appears to be the most robust to this direct substitution.
Formulas that use stratum specific odds and odds ratios to accurately calculate measures of additive
interaction are presented.
Background
Interaction in epidemiology refers to the extent to which
the joint effect of two risk factors on disease differs from
the independent effects of each of the factors [1,2]. The
joint effect is the effect of the presence of both factors on
disease and the independent effect is the effect of each fac-
tor in the absence of the other factor. In terms of their
causal effects on the incidence of a disease, two risk factors
may act independently or interact thereby augmenting (in
case of synergism) or reducing (in case of antagonism) the
effect of one another. Epidemiologists speak of two dis-
tinct types of interaction, biological interaction and statis-
tical interaction. Statistical interaction is a model-
dependent concept [3]. It is considered to be present on a
multiplicative scale when the joint effect of risk factors dif-
fers from the product of the effects of the individual fac-
tors [2]. Statistical interaction is present on the additive
scale when the joint effect of risk factors differs from the
sum of the effects of the individual factors.
Biological interaction on the other hand, describes a prop-
erty of causality and refers to the interdependent action of
two or more factors to produce or prevent an effect [3].
There are limitations in inferring biological/causal inter-
action based on statistical assessment of interaction. Fre-
quently investigators are not able to identify all of the
underlying pathological processes involving measured or
unmeasured intervening variables and their effect on the
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cal interaction is important in epidemiology for predict-
ing disease on the basis of an individual's profile for a set
of risk factors and for planning interventions at the policy
level [4]. The appropriate scale on which to statistically
assess interaction in such a way that it reflects biological
interaction has been a controversial topic in epidemiol-
ogy. It has been argued that the assessment of interaction
on the additive scale is more indicative of the underlying
causal mechanism [3,5]. Thus some authors have advo-
cated that the statistical assessment of interaction is best
done on the additive scale [3,5-11].
Additive interaction is measured in epidemiological stud-
ies primarily using the difference of risk differences also
known as the interaction contrast (IC). In cohort studies,
this can easily be accomplished by fitting linear or log-lin-
ear risk models. However, IC cannot be estimated from
case control studies unless the sampling fractions for cases
and controls are known or can be estimated [12]. Alterna-
tive measures of interaction on the additive scale have
been derived from the IC and are based on risks ratios
(RR) (see appendix). These measures are, the relative
excess risk due to interaction (RERI) also called the inter-
action contrast ratio (ICR), the attributable proportion
due to interaction (AP), and the synergy index (S)
[3,6,7,9]. The ICR is the excess risk due to interaction rel-
ative to the risk without exposure. AP refers to the attrib-
utable proportion of disease which is due to interaction
among persons with both exposures. S is the excess risk
from exposure (to both exposures) when there is interac-
tion relative, to the excess risk from exposure (to both
exposures) without interaction. These measures can be
used to assess additive interaction when the odds ratio
estimates the risk ratio. However, it is recognized that
odds ratios from case-control studies that are not designed
to directly estimate the risk or rate ratio, only approximate
the risk ratio well when the outcome is rare and do so
poorly when the incidence (average risk) of the outcome
of interest is high in the source population [6,13-15]. The
more frequent the outcome becomes, the more the odds
ratio overestimates the risk ratio when it is more than 1
and underestimates the risk ratio when it is less than 1. In
addition, the difference between the odds ratio and the
risk ratio also depends on the magnitude of the effect of
the risk factor. As the effect of a risk factor increases so
does the difference between the odds ratio and the risk
ratio.
The implications of interpreting measures of interaction
on the multiplicative or additive scale when using odds
ratios in place of risk ratios have received little attention
in the literature. Previous studies have shown that the dif-
ferences that could arise from assessing interaction using
odds ratios instead of risk ratios could be so important as
to warrant their careful consideration in epidemiologic
research. Morabia et al noted that using odds ratios
instead of risk ratios can result in discrepant results when
assessing statistical interaction on the multiplicative scale
[16]. Campbell et al further showed that there was a differ-
ence in the estimates of interaction assessed both on the
additive and multiplicative scale when odds ratios were
used in place of risk ratios using ICR [17]. The magnitude
of this difference depended both on the baseline risk as
well as the magnitude of the joint and independent risk
ratios. However, Morabia et al only assessed interaction
on the multiplicative scale [16] and although Campbell et
al, assessed interaction on both the additive and multipli-
cative scale, they only evaluated the performance of ICR
and did not include the other measures of interaction, AP
and S [17]. In addition, the interaction was assessed
within a limited range of effect magnitudes.
All three measures of interaction ICR, AP and S have been
used widely in epidemiologic studies [18-26]. However,
there have been no studies that have assessed the validity
of AP and S as measures of interaction when odds ratios
are used in place of risk ratios. In this paper we assess the
extent to which the three measures of interaction ICR, AP
and S estimated using risk ratios and odds ratios differ as
the incidence of the outcome of interest increases in the
source population and/or as the magnitude of interaction
increases.
Analysis
Notation and measures of additive interaction
Throughout this paper the risk of an outcome under the
influence of two independent binary exposure variables is
considered. The risk of the outcome (the probability of
the outcome given an exposure level) is denoted R while
the odds of the outcome (the ratio of the probability that
the outcome is observed, to the probability of the out-
come not being observed given an exposure level) is
denoted O. Risk and odds are represented by Rij and Oij
respectively, with i indexing exposure to the first variable,
and j indexing exposure to the second variable. The sub-
scripts i and j take values of 0 or 1 in the absence or pres-
ence of exposure respectively. Thus R11 stands for the risk
of the outcome when doubly exposed, while O10 stands
for the odds of the outcome given exposure to the first fac-
tor and non-exposure to the second factor. Similarly,
using RR and OR to denote risk ratio and odds ratio
respectively and using doubly unexposed to both factors
as the reference, RR01 stands for the RR comparing the risk
of the outcome in subjects exposed to the second factor
but not to the first, to the risk in the doubly unexposed
(R01/R00) while OR11 stands for the OR comparing the
doubly exposed to the doubly unexposed (O11/O00).Page 2 of 10
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proposed by Rothman [3,9] – the interaction contrast
ratio (ICR), the attributable proportion due to interaction
(AP) and Rothman's synergy index (S). In this paper,
when these are calculated using the RR as suggested by
Rothman, they are referred to as ICR, AP and S. However,
when they are calculated by substituting ORs for RRs they
are referred to as ICRF, APF and SF respectively (F stands
for 'false' as these are false measures of ICR, AP and S).
Formulas for these measures are given in the appendix.
Simulations and assumptions
Using SAS statistical software version 9 (by the SAS Insti-
tute Inc. Cary, NC, USA) risks for the doubly exposed
(R11) and the doubly unexposed (R00) portions of
100,000 scenarios were simulated using a random uni-
form distribution of risks ranging from 0 to 1. The simu-
lations allowed us, not only to examine a wide range of
combinations of the baseline risk and magnitude of inter-
action, but they also permitted us to describe the shape
and magnitude of discrepancy between the interaction
measures using RR and OR. To simplify the comparison of
the measures of interaction, the effects of each of the expo-
sures were fixed to 2 such that in each cohort RR10 = RR01=
2. Thus to avoid implausible values of R01 and R10 (risk
values greater than 1) this analysis was limited to simu-
lated cohorts in which the baseline risks (R00) were less
than 0.5. This analysis was also restricted to that of two
causative factors such that only cohorts where R01 and R01
were both greater than R00 were included. This did not
preclude R11 from being less than R00 and/or R10 (or R01)
thus allowing for cohorts in which the risk factors were
antagonistic to each other. We also assumed complete
assessment of the population such that risks and odds
(and consequently risk ratios and odds ratios) were
assessed without sampling error. Finally, the absence of
any confounders of the effect of each of the factors in all
the cohorts was also assumed.
Results
Figure 1 depicts the values of ICRF which represent the
estimates of the ICR when odds ratios were used instead
of risk ratios at different baseline risks. If using odds ratios
to assess interaction had resulted in the same estimates as
would have been obtained using risk ratios, the values of
ICRF would have been the same as the ICR values. Hence
we would have expected to get horizontal lines in all five
scenarios of interaction and at all levels of the baseline
risk. However, as illustrated in Figure 1, as the baseline
risk increases, the ICRF values diverge from the expected
values of ICR and this discrepancy is more evident as the
baseline risk approaches 0.15. When there is no interac-
tion between the two risk factors, i.e. when their joint
effect is the exact additive of the two individual effects, the
ICR has a value of 0. However, when the risk ratios are
replaced by the odds ratios, the ICRF has values that
appreciably overestimate ICR thus indicating the presence
of interaction. This is noticeable starting from when the
baseline risk approaches 0.10, becoming very prominent
at a baseline risk level of 0.30 at which point the value of
ICRF is 15. In these instances, one would conclude that
there is evidence of interaction on the additive scale even
though the same data would not suggest the presence of
additive interaction had risk ratios been used. This dis-
crepancy in the estimates of ICR and ICRF is also more
pronounced when the interaction is more than additive as
compared to when the interaction is less than additive.
When the interaction is more than additive and more than
multiplicative, the difference in the values of ICR and
ICRF becomes evident even at baseline risks as low as
0.05. At this baseline risk, the value of ICRF is 7, which is
almost double the estimate that would have been
The impact of baseline risk (R00 and interaction magnitude on the discrepancy b tw en the interaction contrast ratio calcu-lat  using risk ratios (ICR) and th t calculated using ds ratios (ICRF). E ch curve repres nts a spec fic value of the ICR and ch ges on th  vertical sc le re res t h  magni-ude of the disc epa cyFigure 1
The impact of baseline risk (R00 and interaction mag-
nitude on the discrepancy between the interaction 
contrast ratio calculated using risk ratios (ICR) and 
that calculated using odds ratios (ICRF). Each curve 
represents a specific value of the ICR and changes on 
the vertical scale represent the magnitude of the dis-
crepancy. Interaction scenarios: Less than additive; ICR = -
2.5 and -1.5; Exactly additive: ICR = 0; More than additive 
and less than multiplicative ICR = 0.5; Exactly multiplicative: 
ICR = 1; More than additive and more than multiplicative: 
ICR = 2 and 4
-10
-5
0
5
10
15
20
r00
0. 0 0. 1 0. 2 0. 3 0. 4
ICR=4
ICR=2
ICR=1.0
ICR=0.0
ICR=0.5
ICR=-1.5
ICR=-2.5Page 3 of 10
(page number not for citation purposes)
Epidemiologic Perspectives & Innovations 2006, 3:5 http://www.epi-perspectives.com/content/3/1/5obtained if risk ratios had been used instead to give an ICR
value of 4. However, when the interaction is less than
additive, the difference in the ICR and the ICRF estimates
is not very evident until the baseline risk is approximately
0.20. In the scenario where the ICR value is -1.5, the ICRF
estimate is -1.9, which is not very different from the ICR
value at a baseline risk of 0.10. However, this discrepancy
increases markedly such that at a baseline risk of 0.20, the
ICRF has a value -2.6. Figure 4 also illustrates the magni-
tude of the differences between ICR and ICRF for different
combinations of baseline risk and interaction magnitude.
A similar relationship is noted when additive interaction
is assessed using AP. As illustrated in the Figure 2, the dif-
ference in the magnitude of APF from AP increases with an
increase in the baseline risk. However, this difference only
becomes appreciably evident at a baseline risk of approx-
imately 0.15, which is higher than that seen when using
ICR. At the baseline risk of 0.05, there is a small difference
in the AP and APF values. The AP values of 0, 0.25 and
0.40 have corresponding APF values of 0.03, 0.32 and
0.49 respectively. However, at the baseline risk of 0.15,
the differences in magnitude are noticeable as the corre-
sponding APF values are 0.06, 0.55 and 0.77 respectively.
Furthermore, the differences in the estimates of AP and
APF are not as pronounced when the interaction is more
than additive, as was the case when using ICR to measure
interaction. However, as opposed to using ICR, the differ-
ence is more pronounced when the interaction is less than
additive. When the value of AP is -1, the difference in the
estimates of AP and APF are not substantial even at base-
line risk levels of 0.25 where the value of APF is -1.8. How-
ever, when the magnitude of the less than additive
interaction between the two risk factors increases and the
AP value is -5, the difference in the estimates of AP and
APF become very marked even at a lower baseline risk of
approximately 0.05 such that the value of APF is 6.4.
As illustrated in Figure 3, a similar pattern is also observed
when assessing the presence of additive interaction using
S. The discrepancy in the values of S and SF increases
when the baseline risk increases and the magnitude of
interaction increases. When there is exact additivity, indi-
cating no interaction on the additive scale, S has a value of
1. However, there is divergence of the values of SF from S,
in the scenario where we would have expected exact addi-
tivity if risk ratios had been used. This is appreciably evi-
dent when the baseline risk is approximately 0.25 where
the value of SF is 1.5 instead of 1. This noticeable differ-
ence is at a much higher baseline risk than that seen when
the two previous measures of interaction, ICR and AP
were used. As was noted in the case of ICR, the differences
in the estimates of S and SF become more evident at lower
levels of baseline risk when the is interaction is greater
than additive. For example, when the interaction is more
than additive and more than multiplicative, the difference
in the two estimates is appreciable even at baseline risks as
low as 0.05 such that the value of SF is 4.2, instead of an
S value 3. Because of the predetermined risk ratio of 2 for
both risk factors, for our simulations the lowest value that
S can have is -0.5. When there is less than additive interac-
tion the discrepancy in the values of S and SF decreases as
the value of S approaches 1.
The effect of calculating the three interaction measures
using odds ratios instead of risk ratios is further illustrated
in Figure 4. The size of the bubbles represents the magni-
tude of the difference between the interaction measures
using odds ratios and risk ratios. The lines represent the
scenario when there is exact additivity. Panel 4a (left
upper corner) represents the absolute difference in the val-
The impact of baseline risk (R00 and interaction magnitude on the discrepancy b tw en the attributable pr portion du to int raction calculated using risk atios (AP) and that calcu-la  us ng odds ra ios (APF). E ch curv represents a spe-cific valu  of AP and changes on t e verti al scal  repres nt m g itude of the di cr pancyFigure 2
The impact of baseline risk (R00 and interaction mag-
nitude on the discrepancy between the attributable 
proportion due to interaction calculated using risk 
ratios (AP) and that calculated using odds ratios 
(APF). Each curve represents a specific value of AP 
and changes on the vertical scale represent the mag-
nitude of the discrepancy. Interaction scenarios: Less 
than additive; AP = 5 and -1; Exactly additive: AP = 0; More 
than additive and less than multiplicative AP = 0.14; Exactly 
multiplicative: AP = 0.25; More than additive and more than 
multiplicative: AP = 0.40 and 0.57 (These correspond to the 
ICR values depicted in Figure 1).
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these estimates increases with an increase in the baseline
risk. In addition, the difference is more evident in the
presence of interaction that is more than additive com-
pared to the other types of interaction as indicated by the
size of the bubbles.
Panel 4b (right upper corner) is a representation of the
estimates of interaction calculated using AP and APF. As
was the case for ICR/ICRF, the differences in the absolute
values increase as the baseline risk increases. However, in
this instance the increase in the discrepancy between AP
and APF is more gradual in contrast to ICR/ICRF, and the
difference is more prominent when the interaction is less
than additive. Panel 4c (bottom left corner) represents the
absolute difference between S and SF and Panel 4d (bot-
tom right corner) represents the log difference between S
and SF. The pattern is very similar to that seen when the
presence of interaction was assessed using ICR/ICRF. The
difference increases as the baseline risk increases and it is
more prominent when there is interaction that is more
than additive.
Discussion
Our analysis shows that measures of additive interaction
calculated by substituting odds ratios in place of risk ratios
may not be reliable. The discrepancy between the two
depends on the measure of interaction used, the type of
interaction present and the baseline risk of the outcome.
For more than additive interactions the difference is more
pronounced for the ICR and S and the least difference is
noticed for AP. For less than additive interactions, the
least difference is noticed for ICR and S but it is more pro-
nounced for AP. For all of the three measure of interac-
tion, when odds ratios were substituted in the place of risk
ratios, the difference in magnitude increased with an
increase in the baseline risk and magnitude of interaction.
Additionally, for all three measures, interaction assessed
to be more (or less) than additive using the RR was always
found to be also more (or less) than additive, albeit of
higher absolute magnitude, when the OR was used. How-
ever, an absence of additive interaction (exact additivity)
could be misleadingly assessed as the presence of an inter-
action when using the OR. There was no cross over, that
is, never did a more than additive interaction appear to be
less than additive and vice versa. Thus when evaluating
the interaction between two risk factors using the OR and
using the ICR or S as measure of interaction, investigators
should be cautious about affirming the presence of more
than additive interaction, particularly when the study out-
come is not rare. Similarly, investigators should be careful
when interpreting less than additive interaction based on
OR, particularly if AP is used.
Morabia et al. previously described a similar discrepancy
between the OR and RR when assessing interaction but
this was limited to interaction on the multiplicative scale
[16]. Campbell et al also reported similar discrepancies
both on the multiplicative scale and on the additive scale
using the ICR [17]. Although most authors tend to assess
interaction on the multiplicative scale when using ORs,
particularly in the context of case-control study designs
and/or logistic regression analysis [22-24,26], in this
paper we only evaluated the assessment of interaction on
the additive scale. In simulations using individual level
etiologic models (such as the Potential Outcomes Model
and the Sufficient and Component Cause Model), the
additive scale appeared to be a better indicator of the rel-
ative frequency of antagonistic or synergistic interactions
in the study population [3. 5]. Thus the additive scale has
been argued to be the scale of choice to assess interaction.
The three measures ICR, AP and S were developed inde-
pendently. ICR and AP were derived directly from IC
which is the primary measure of additive interaction as
illustrated in the formulae in the appendix. ICR expresses
IC as a proportion to the baseline risk (R00) and AP
expresses IC as a proportion of the joint effect of the two
risk factors (R11). S is the ratio of the observed and
expected effects of the difference between the joint effect
and the baseline risk. Of the three measures of interaction
on the additive scale (ICR, AP, and S), the ICR appears to
be most frequently utilized [3,25,27]. However, ICR may
not be the best measure to use for assessing interaction in
all circumstances. Our study suggests that AP is more
robust to directly substituting ORs in place of RRs. It is less
affected, compared to ICR and S, by changes in the type of
interaction or baseline risk when substituting risk ratios
by odds ratios. Furthermore, in the analysis of additive
interaction while adjusting for confounding (using addi-
tional covariates in regression models), S has been shown
to be the most reliable as it does not vary across strata of
the additional covariates [12]. We suggest that all three
measures be used when assessing additive interaction and
that any discrepancies between the three should be
resolved by a careful consideration of the individual risk
factors being evaluated, the baseline risk of the outcome,
as well as the presence or not of confounders.
Extensive work has been done to accommodate odds
ratios in epidemiologic studies [28]. However, to the best
of our knowledge, these do not address the measurement
of additive interaction when left only with odds ratios as
measures of effect. Campbell et al provide a formula that
shows how a measure of multiplicative interaction based
on risk ratios can be estimated using odds ratios and base-
line risk [17]. We have derived formulas to calculate the
three additive interaction measures using odds ratios. The
formulas presented in the appendix could be used to morePage 5 of 10
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tion, similar to what would have been obtained, had the
risk ratio been used. Odds for each level defined by com-
binations of exposure and covariate can be estimated
using parameters from a logistic regression. The formulas
could easily be implemented using a spreadsheet (see
Additional File 1).
Conclusion
Substituting ORs for RRs, when calculating measures of
additive interaction (ICR, AP and S), may result in mis-
leading conclusions. The magnitude of the discrepancy in
the measures of interaction increases with an increase in
the baseline incidence of the outcome and depends on the
measure of interaction used as well as the type of interac-
tion. We recommend that formulas modified for direct
use of odds and odds ratios be employed for more accu-
rate assessment of additive interaction.
Appendix
I Measures of additive interaction
The interaction contrast (IC) which is the basic measure of
additive interaction is applicable when the risks for each
stratum defined by 2 variables are available. It is given by:
IC = R11 - R10 - R01 + R00 Eq. 1
However when only the risk ratios (and not the risks for
each level defined by exposure-covariate combinations)
are available, the following extensions of IC can be used
to evaluate additive interaction [3,9]
IC = R11 - R10 - R01 + R00
ICR and AP thus have a null value of 0 while S has a null
value of 1. With some study designs, such as cross-sec-
tional studies or case-control studies, the only measure of
effect that can be obtained is the odds ratio, OR. To eval-
uate interaction on the additive scale some authors have
simply substituted OR for RR in equations 2–4. We refer
to ICR, AP and S calculated using the OR as ICRF, APF,
and SF respectively. If the OR is not a good estimate of the
RR then ICRF, APF and SF may not be good estimates of
ICR, AP and S respectively.
To correctly calculate ICR, AP and S, from studies in which
only the OR is available one simply needs to calculate the
RR based on the OR and substitute it in equations 2–4
(instead of directly substituting OR for RR).
To calculate the RR using the OR, consider a single binary
exposure scenario:
Thus
ICR
IC
R
RR RR RR Eq.211 10 01= = − − +
00
1
AP
IC
R
RR RR RR
RR
Eq.311 10 01
11
= =
− − +
11
1
S
R R
R R R R
RR
RR RR
Eq.4=
−
−( ) + −( ) =
−
−( ) −( )
11 00
10 00 01 00
11
10 01
1
1 1
R
O
O
Eq.1
1
11
5=
+
R
O
O
Eq.60
0
01
=
+
The impact of baseline risk (R00 and interaction magnitude on the discrepancy b tw en the synergy index calculated using risk ratios (S) and that calculated us g odds ratios (SF). Eachcurve represents a spe fi v lue of S a  ha ges o  the ver-cal scal  repre ent th  magnitude of the d scr p ncyFigure 3
The impact of baseline risk (R00 and interaction mag-
nitude on the discrepancy between the synergy index 
calculated using risk ratios (S) and that calculated 
using odds ratios (SF). Each curve represents a spe-
cific value of S and changes on the vertical scale rep-
resent the magnitude of the discrepancy. Interaction 
scenarios: Less than additive; S = -0.25 and 0.25; Exactly 
additive: S = 1; More than additive and less than multiplica-
tive S = 1.25.; Exactly multiplicative: S = 1.5; More than addi-
tive and more than multiplicative: S = 2 and 3 (These 
correspond to the ICR values depicted in Figure 1).
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scenario then
Substituting equations 8–10 in equations 2–4:
Thus, to more accurately calculate ICR, AP and S, the odds
of the outcome for each level defined by combinations of
the 2 covariates being evaluated for interaction, need to be
known.
These odds can be estimated using parameters from a
logistic regression and sampling probabilities (when
needed) as follows {[3] pp 416–422}:
Where
k is the number of exposure levels defined by combina-
tions of covariates (for example for 2 binary covariates, k
= 4);
Wj are mutually exclusive indicator variables for each of
the k-l exposure levels (excluding a referent level);
βj are the estimated log odds ratios comparing each index
j level to the referent level;
α* is the estimated intercept parameter from the logistic
regression;
f and g are case and control sampling probabilities respec-
tively.
Note that equation 16 is based on the fact that in case-
control studies, the intercept from a logistic regression
model is the log of the odds of the outcome inflated by the
log of the ratio of case to control sampling probabilities
[12].
In cohort studies, cross sectional studies, or case control
studies with complete ascertainment of both cases and
controls, in which analysts use logistic regression, f = g =
1, and equation 16 reduces to equation 17.
Equations 12, 14 and 15 can be easily implemented using
a spreadsheet (see Additional File 1).
II. SAS code
data one simulate;
do sample = 1 to 100000;
r00 = round((0.00001 + ranuni(11)),.01);
r11 = round ((0.00001 + ranuni(14)), 0.01);
r01 = .;
if r00<0.5 then r01 = 2*r00;
r10 = .;
if r00<0.5 then r10 = 2*r00;
rr11 = r11/r00;
rr10 = r10/r00;
rr01 = r01/r00;
or11 = (r11*(1-r00))/(r00*(1-r11));
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Epidemiologic Perspectives & Innovations 2006, 3:5 http://www.epi-perspectives.com/content/3/1/5or01 = (r01*(1-r00))/(r00*(1-r01));
or10 = (r10*(1-r00))/(r00*(1-r10));
icr = round(((r11/r00)-(r10/r00)-(r01/r00)+1), .01);
ap = round(((r11/r00)-(r01/r00)-(r10/r00)+1)/(r11/
r00), .01);
s = round(((rr11-1)/(rr10 + rr01 -2)), .01);
icrf = round((or11- or10- or01 + 1), .01);
apf = round((or11-or01-or10+1)/or11, .01);
sf = round((or11-1)/(or10 + or01 -2), .01);
icrdif = abs(icrf-icr);
apdif = abs(apf-ap);
sdif = abs(sf-s);
logsdif = abs(log(sf) – log(s));
output simulate;
end;
run;
proc sort data = simulate; by r00 ; run;
axis1 order = -10 to 20 by 5 label = (a = 90 r = 0 'ICRF' h
= 2);
axis2 order = 0 to 0.4 by 0.1;
procgplot data = simulate ; where icr in (-2.5,-1.5, 0,0.5,1,
2, 4,);
symbol1 i = spline v = star h = 0.5 c = black;
symbol2 i = spline v = plus h = 0.5 c = red;
symbol3 i = spline v = circle h = 0.5 c = blue;
symbol4 i = spline v = diamond h = 0.5 c = green;
symbol5 i = spline v = square h = 0.5 c = violet;
symbol6 i = spline v = triangle h = 0.5 c = indigo;
symbol7 i = spline v = dot h = 0.5 c = black;
plot icrf*r00 = icr/haxis = axis2 vaxis = axis1 nolegend;
run;quit;
axis1 order = -10 to 3 by 1 label = (a = 90 r = 0 'APF' h = 2);
axis2 order = 0 to 0.4 by 0.1;
proc gplot data = simulate ;
where icr in (-2.5,-1.5, 0, 0.5,1, 2, 4,);
symbol1 i = spline v = star h = 0.5 c = black;
symbol2 i = spline v = plus h = 0.5 c = red;
symbol3 i = spline v = circle h = 0.5 c = blue;
symbol4 i = spline v = diamond h = 0.5 c = green;
symbol5 i = spline v = square h = 0.5 c = violet;
symbol6 i = spline v = triangle h = 0.5 c = indigo;
symbol7 i = spline v = dot h = 0.5 c = black;
plot apf*r00 = ap/haxis = axis2 vaxis = axis1 nolegend;
run;quit;
Discrepancy between ICR, AP, S and logS calculatedusing the RR and the OR for different values of R11 and R00Figure 4
Discrepancy between ICR, AP, S and logS calculat-
edusing the RR and the OR for different values of R11 
and R00. The size of each bubble is directly proportional to 
the absolute difference in the interaction measures calculated 
using odds ratios and risk ratios at each value of R11 and R00. 
The line in each plot represents the set of R11 and R00 scenar-
ios in which there is exact additivity (ICR = AP = 0; S = 1).
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Epidemiologic Perspectives & Innovations 2006, 3:5 http://www.epi-perspectives.com/content/3/1/5axis1 order = -5 to 15 by 1 label = (a = 90 r = 0 h = 1 'SF' h
= 2);
axis2 order = 0 to 0.4 by 0.1;
proc gplot data = simulate ;
where icr in (-2.5,-1.5, 0, 0.5,1, 2, 4,);
symbol1 i = spline v = star h = 0.5 c = black;
symbol2 i = spline v = plus h = 0.5 c = red;
symbol3 i = spline v = circle h = 0.5 c = blue;
symbol4 i = spline v = diamond h = 0.5 c = green;
symbol5 i = spline v = square h = 0.5 c = violet;
symbol6 i = spline v = triangle h = 0.5 c = indigo;
symbol7 i = spline v = dot h = 0.5 c = black;
plot sf*r00 = s/haxis = axis2 vaxis = axis1 nolegend;
run;quit;
*bubble plots;
data anno2;/*this superimposes a line where there is
exact additivity ie icr = 0, rr11 = 3 */function = 'move'; xsys
= '1'; ysys = '1'; x = 0; y = 0; output;
function = 'draw'; xsys = '1'; ysys = '1'; color = 'red'; x =
(100/3)*2; y = 100; output;
run;
axis1 order = 0 to 1 by .1;
axis2 order = 0 to 0.4 by 0.1;
proc gplot data = simulate ;
where icr in (-3, -2, -1, 0, 1,3, 5);
bubble r11*r00 = icrdif/anno = anno2 haxis = axis2 vaxis
= axis1 bsize = 100 bcolor = blue;
bubble r11*r00 = apdif/anno = anno2 haxis = axis2 vaxis
= axis1 bsize = 100 bcolor = blue;
bubble r11*r00 = sdif/anno = anno2 haxis = axis2 vaxis =
axis1 bsize = 100 bcolor = blue;
bubble r11*r00 = logsdif/anno = anno2 haxis = axis2
vaxis = axis1 bsize = 100 bcolor = blue;
run;quit;
Abbreviations
R: Risk
O: Odds
RR: Risk ratio
OR: Odds ratio
RERI: Relative excess risk due to interaction
ICR: Interaction contrast ratio
AP: Attributable proportion due to Interaction
S: Rothman's synergy index
ICRF: Interaction contrast ratio calculated by substituting
odds ratios for risk ratios
APF: Attributable proportion due to interaction calculated
by substituting odds ratios for risk ratios
SF: Rothman's synergy index calculated by substituting
odds ratios for risk ratios
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